MORGAN STANLEY - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$965,369
-25.3%
107,742
-6.2%
0.00%
Q2 2023$1,292,007
-1.3%
114,845
+1.1%
0.00%
Q1 2023$1,309,017
+75.3%
113,630
+76.4%
0.00%
Q4 2022$746,744
-54.6%
64,430
-50.3%
0.00%
Q3 2022$1,645,000
+5.0%
129,540
-43.2%
0.00%
Q2 2022$1,567,000
-46.6%
228,050
-25.1%
0.00%
Q1 2022$2,935,000
-34.0%
304,543
-18.6%
0.00%
-100.0%
Q4 2021$4,445,000
+163.8%
373,920
+260.3%
0.00%
Q3 2021$1,685,000
+1619.4%
103,778
+2128.9%
0.00%
Q2 2021$98,000
+4800.0%
4,656
+3595.2%
0.00%
Q1 2021$2,000
-99.6%
126
-99.5%
0.00%
Q4 2020$510,00024,2750.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders